Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × TroVax × Clear all

Phase

Phase 2 5 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cyclophosphamide 377 Radiotherapy 250 fludarabine 209 Gemcitabine 192 Cisplatin 185 pembrolizumab 164 Nivolumab 164 Paclitaxel 157 Carboplatin 146 Magnetic Resonance Spectroscopy 145 fludarabine phosphate 140 Irinotecan 119 Bevacizumab 119 Temozolomide 116 Cytarabine 114 Capecitabine 110 Specimen Handling 106 Radiosurgery 105 Radiation 103 Docetaxel 101 Etoposide 100 Oxaliplatin 99 Fluorouracil 99 Biopsy 99 Dexamethasone 98 Rituximab 96 Ipilimumab 96 Lenalidomide 89 Sorafenib 88 Filgrastim 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02390063 2020-02-10

Vaccination in Prostate Cancer (VANCE)

University of Oxford

Phase 1 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡